Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Shanghai Fosun Pharmaceutical Group Co., Ltd.    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.

(600196)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
50.29 49.9 50.02 50.46 51.74 Last
25205870 24253310 26142580 32181270 52851630 Volume
+0.38% -0.78% +0.24% +0.88% +2.54% Change
Financials
Sales 2020 31 377 M 4 841 M 4 841 M
Net income 2020 3 531 M 545 M 545 M
Net Debt 2020 14 857 M 2 292 M 2 292 M
P/E ratio 2020 39,6x
Yield 2020 0,84%
Sales 2021 39 423 M 6 083 M 6 083 M
Net income 2021 4 211 M 650 M 650 M
Net Debt 2021 15 456 M 2 385 M 2 385 M
P/E ratio 2021 31,1x
Yield 2021 0,95%
Capitalization 122 B 18 748 M 18 749 M
EV / Sales 2020 4,35x
EV / Sales 2021 3,47x
Nbr of Employees 31 370
Free-Float 58,6%
More Financials
Company
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 5 areas of activities: - research, development and manufacturing of medicines (74.9% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases; - sale of medical equipments and diagnosis products (14.7%); - medical and... 
More about the company
Notations Surperformance© of Shanghai Fosun Pharmaceutical Group Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.
01/22SHANGHAI FOSUN PHARMACEUTICAL : Voluntary announcement - progress update on the ..
PU
01/11SHANGHAI FOSUN PHARMACEUTICAL : Chinese Regulators Accept Fosun Pharma's Clinica..
MT
01/11SHANGHAI FOSUN PHARMACEUTICAL : Overseas regulatory announcement (h shares)
PU
01/04SHANGHAI FOSUN PHARMACEUTICAL : Overseas regulatory announcement (h shares)
PU
01/04SHANGHAI FOSUN PHARMACEUTICAL : Fosun Pharma Secures Chinese Regulator's OK for ..
MT
2020China's Fosun plans plant to make BioNTech's COVID-19 vaccine -Caixin
RE
2020Hong Kong Stocks End 2020 Moderately Higher; Fosun Pharma Jumps 3% on Vaccine..
MT
2020MARKET CHATTER : Fosun Pharma Plans COVID-19 Vaccine Tie-up with BioNTech in Chi..
MT
2020China's Fosun to set up JV with BioNTech to make COVID-19 vaccines-Caixin
RE
2020SHANGHAI FOSUN PHARMACEUTICAL : Connected transaction - entering into the partne..
PU
2020Chinese Shares Rebound at Close; Jiangsu Hengrui Medicine Jumps 8% on Clinica..
MT
2020Pfizer to Complete First Covid-19 Vaccine Shipments in U.S.
DJ
2020PRESS RELEASE : BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-..
DJ
2020SHANGHAI FOSUN PHARMACEUTICAL : Fosun Pharma to Buy 100 Million Doses of BioNTec..
MT
2020SHANGHAI FOSUN PHARMACEUTICAL : BioNTech and Fosun Pharma to Supply China with m..
PU
More news
News in other languages on SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.
2020PLANÈTE BOURSE : la revue de presse du mercredi 16 décembre 2020
2020SHANGHAI FOSUN PHARMACEUTICAL : BioNTech ha benchmark per prezzo vaccini per pae..
2020La vacuna de Pfizer no será la panacea para las naciones asiáticas
2020EN DIRECT DES MARCHES : AXA, Aperam, Crédit Agricole, Engie, Ahold Delhaize, Ant..
2020Borsa Shanghai, si interrompe rally, vaccini sperimentali alimentano timori s..
More news
Analyst Recommendations on SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.
More recommendations
Chart SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.
Duration : Period :
Shanghai Fosun Pharmaceutical Group Co., Ltd. Technical Analysis Chart | 600196 | CNE000000X38 | MarketScreener
Technical analysis trends SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 42,50 CNY
Last Close Price 51,74 CNY
Spread / Highest target 34,6%
Spread / Average Target -17,9%
Spread / Lowest Target -58,5%
EPS Revisions
Managers and Directors
NameTitle
Xiao Hui Guan Executive President & Chief Financial Officer
Yu Qing Chen Co-President
Ke Xin Wang Co-President
Dong Ming Li Co-President
Yi Fang Wu Chairman
Sector and Competitors